The government ordered the constitution of an inter-ministerial group to review India’s foreign direct investment (FDI) norms in Rs 47,000-crore pharmaceutical sector. The directions were issued in a meeting of the Cabinet Committee of Economic Affairs , chaired by prime minister Manmohan Singh.
The inter-ministerial group has to examine all concerns related to foreign direct investment (FDI) in the pharmaceutical sector and take a final call on whether any form of restriction is required.
